Pharming reported revenue of $162.66M and net income of -$10.34M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2018 | Dec2019 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||
| Revenue | 52.63M | 93.20M | 46.60M | 50.10M | 54.20M | 151.00M | 42.54M | 54.90M | 66.66M | 81.20M | 55.60M | 74.10 | 74.80M | 204.50M | 79.10M | 97.30M | 106.50 | 72.40M | 162.66M | |||||||
| Cost of RevenueCost of Rev | 5.98M | -14.78M | 4.90M | 50.10M | 2.30M | 11.30M | 4.08M | 9.80M | 8.29M | 25.21M | 8.39M | 16.37M | 6.80M | 35.40M | 8.32M | 7.10M | 45.50M | 6.64M | 21.19M | |||||||
| Gross Profit | 46.65M | 83.80M | 41.70M | 46.10M | 51.90M | 139.70M | 38.47M | 87.64M | 58.37M | 74.10M | 47.20M | 113.31M | 68.00M | 181.30M | 70.80M | 90.20M | 85.40 | 65.80M | 141.47M | |||||||
| Operating items | ||||||||||||||||||||||||||
| Research & DevelopmentR&D | -13.32M | 35.81M | -12.30M | -41.60M | -15.62M | -20.90M | -20.75M | -11.60M | -18.50M | -40.12M | -20.70M | -60.80M | -21.10M | -23.40M | -32.10 | -25.56M | -57.82M | |||||||||
| Selling, General & AdministrativeSG&A | -7.43M | 21.45M | -12.00M | -28.50M | -9.98M | -11.00M | -10.89M | -24.10M | -15.09M | -30.71M | -15.30M | -46.00M | -22.49M | -17.00M | -20.00 | -15.20M | -30.16M | |||||||||
| Operating ExpensesOpex | -20.75M | 57.27M | -24.30M | -70.10M | -25.60M | -31.90M | -31.64M | -35.70M | -33.59M | -70.83M | -36.00M | -106.80M | -43.59M | -40.40M | -52.10 | -40.76M | -87.98M | |||||||||
| Operating IncomeOp. Inc | -1.68M | 17.20M | 2.80M | 17.80M | 7.80M | 28.40M | -13.66M | 5.30M | 1.91M | 1.10M | -16.30M | -19.43M | 4.10M | -15.30M | -7.00M | 15.80M | 6.20 | -4.90M | -3.60M | |||||||
| EBIT | -1.68M | -14.63M | 2.80M | 17.80M | 7.80M | 28.40M | -13.66M | 5.30M | 1.91M | 1.10M | -16.30M | -19.43M | 4.10M | -15.30M | -7.00M | 15.80M | 6.20 | -4.90M | -3.60M | |||||||
| Non-operating items | ||||||||||||||||||||||||||
| Non Operating Interest Expenses | -5.24M | |||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 1.80M | -2.67M | -4.46M | 1.88M | -6.34M | 0.22M | 3.58M | -2.15M | 1.89M | -4.49M | 1.72M | -13.62M | 0.54M | 1.72M | ||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 5.27M | -14.91M | 2.80M | 9.30M | 0.12M | -0.80M | -1.25M | -3.66M | 1.80M | -2.94M | 0.82M | -6.84M | 0.60M | -1.09M | -2.18M | 3.24M | -7.12M | |||||||||
| Net income details | ||||||||||||||||||||||||||
| EBT | -19.56M | 12.79M | 4.60M | 17.80M | 9.30M | 33.10M | -16.34M | -13.29M | 3.31M | -12.01M | -16.08M | -16.68M | 1.51M | -15.20M | -11.49M | 12.70M | 4.80 | -4.36M | -1.71M | |||||||
| Tax ProvisionsTaxes | -1.75M | 7.07M | -0.80M | -3.79M | -0.20M | -4.80M | 4.47M | 2.40M | 0.16M | 1.46M | 4.20M | 3.02M | -2.50M | 0.50M | -3.10M | -5.20M | 0.50 | -0.46M | -1.86M | |||||||
| Profit After TaxPAT | -0.32M | 14.40M | 3.50M | 15.70M | 9.10M | 28.30M | -12.21M | 1.30M | 3.46M | -3.10M | -12.40M | -13.67M | -1.10M | -14.70M | -14.89M | -14.70M | 5.30 | -10.24M | -10.34M | |||||||
| Income from Non-Controlling InterestsInc. Minority | -0.17M | 0.17M | -0.31M | |||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -17.81M | 15.19M | 5.40M | 21.59M | 9.50M | 37.90M | -20.80M | -15.69M | 3.15M | -13.48M | -20.28M | -19.70M | 4.01M | -15.70M | -8.39M | 17.90M | 4.30 | -3.90M | 0.15M | |||||||
| Consolidated Net IncomeConsol Net Inc. | -17.81M | 15.19M | 5.40M | 21.59M | 9.50M | 37.90M | -20.80M | -15.69M | 3.15M | -13.48M | -20.28M | -19.70M | 4.01M | -15.70M | -8.39M | 17.90M | 4.30 | -3.90M | 0.15M | |||||||
| Income towards Parent CompanyParent Net Inc | -17.81M | 15.19M | 5.40M | 21.59M | 9.50M | 37.90M | -20.80M | -15.69M | 3.15M | -13.48M | -12.45M | -13.67M | 11.41M | -11.84M | -14.72M | -2.79M | 5.38M | -5.21M | -3.58M | |||||||
| Net Income towards Common StockholdersNet Income | -17.81M | 15.19M | 5.40M | 21.59M | 9.50M | 37.90M | -20.80M | -15.69M | 3.15M | -13.48M | -12.45M | -13.67M | 11.41M | -11.84M | -14.72M | -2.79M | 5.38M | -5.21M | -3.58M | |||||||
| Additional items | ||||||||||||||||||||||||||
| EPS (Basic) | -0.28 | 0.24 | 0.08 | 0.34 | 0.15 | 0.58 | -0.32 | -0.24 | 0.05 | -0.21 | -0.19 | -0.21 | 0.17 | -0.18 | -0.22 | -0.04 | 0.08 | -0.08 | -0.05 | |||||||
| EPS (Diluted) | -0.26 | 0.22 | 0.08 | 0.31 | 0.14 | 0.54 | -0.29 | -0.22 | 0.04 | -0.19 | -0.17 | -0.19 | 0.16 | -0.15 | -0.19 | -0.04 | 0.07 | -0.07 | -0.05 | |||||||
| Shares Outstanding | 63.63M | 64.20M | 64.20M | 64.20M | 64.20M | 64.87M | 64.87M | 64.87M | 64.87M | 65.70M | 65.70M | 65.70M | 65.70M | 67.13M | 67.13M | 67.13M | 67.13M | 68.88M | 68.88M | 68.88M | ||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 68.27M | 70.12M | 70.12M | 70.12M | 70.12M | 70.71M | 70.71M | 70.71M | 70.71M | 72.55M | 72.55M | 72.55M | 72.55M | 78.54M | 78.54M | 78.54M | 78.54M | 74.69M | 74.69M | 74.69M | ||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 64.87M | 65.63M | 67.11M | 68.03M | 70.17M | |||||||||||||||||||||
| EBITDA | -1.68M | -14.63M | 2.80M | 17.80M | 7.80M | 28.40M | -13.66M | 5.30M | 1.91M | 1.10M | -16.30M | -19.43M | 4.10M | -15.30M | -7.00M | 15.80M | 6.20 | -4.90M | -3.60M | |||||||
| Interest ExpensesInt Expense | -5.24M | |||||||||||||||||||||||||
| Tax Rate | 8.95% | 55.29% | -17.39% | -21.28% | -2.15% | -14.50% | -27.34% | -18.05% | 4.75% | -12.19% | -26.12% | -18.09% | -165.13% | -3.29% | 26.97% | -40.94% | 10.42% | 10.53% | 108.58% |